Outcomes in cervical screening using various cytology technologies: What's age got to do with it?

European Journal of Cancer Prevention

Volumn 22, Issue 4, 2013, Pages 367-373

  Barken, Sidsel S ^a   Rebolj, Matejka ^a   Lynge, Elsebeth ^a   Junge, Jette ^b   Rygaard, Carsten ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

cervical intraepithelial neoplasia; cytology; technology

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CALCULATION; CANCER SCREENING; FEMALE; GROUPS BY AGE; HUMAN; LABORATORY AUTOMATION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PRIORITY JOURNAL; SQUAMOUS CELL; UNIVERSITY HOSPITAL; UTERINE CERVIX CYTOLOGY;

ADULT; AGE FACTORS; CERVIX UTERI; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84878818952     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328359cbe0     Document Type: Article

References (26)

1. Agorastos T, Lambropoulos AF, Sotiriadis A, Mikos T, Togaridou E, Emmanouilides CJ (2009). Prevalence and distribution of high-risk human papillomavirus in Greece. Eur J Cancer Prev 18:504-509.
2. Anttila A, Pokhrel A, Kotaniemi-Talonen L, Hakama M, Malila N, Nieminen P (2011). Cervical cancer patterns with automation-assisted and conventional cytological screening: a randomized study. Int J Cancer 128:1204-1212.
3. Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J (2008). Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol 111:167-177.
4. Austin RM (2012). Liquid-based cytology vs. conventional cytology: two perspectives on the great cytology debate are presented. Available at: http://laboratory-manager.advanceweb.com/features/top-story/liquid- basedcytology-vs-conventional-cytology.aspx?CP=3 [Accessed 14 March 2012].
5. Bjerregaard B, Larsen OB (2011). The Danish Pathology Register. Scand J Public Health 39 (Suppl):72-74.
6. Castle PE (2010). Screening: HPV testing for cervical cancer: the good, the bad, and the ugly. Nat Rev Clin Oncol 7:364-365.
7. Castle PE, Bulten J, Confortini M, Klinkhamer P, Pellegrini A, Siebers AG, et al. (2010). Age-specific patterns of unsatisfactory results for conventional Pap smears and liquid-based cytology: data from two randomised clinical trials. BJOG 117:1067-1073.
8. Danmarks Statistik (2011a). StatBank Denmark. Mid-year pupulation (population size on 1 July) by area, year, sex and age. Available at: http://www.statistikbanken.dk/statbank5a/default.asp?w=1366 [Accessed 18 October 2011].
9. Danmarks Statistik (2011b). StatBank Denmark. Population size on 1 January by sex, area, age and year. Available at: http://www.statistikbanken.dk/ statbank5a/default.asp?w=1680 [Accessed 7 December 2011].
10. Ferris DG, Heidemann NL, Litaker MS, Crosby JH, Macfee MS (2000). The efficacy of liquid-based cervical cytology using direct-to-vial sample collection. J Fam Pract 49:1005-1011.
11. Fremont-Smith M, Marino J, Griffin B, Spencer L, Bolick D (2004). Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study. Cancer 102: 269-279.
12. Gjerstorff ML (2011). The Danish Cancer Registry. Scand J Public Health 39 (Suppl):42-45.
13. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, et al. (2000). Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 87:221-227.
14. Kirschner B, Simonsen K, Junge J (2006). Comparison of conventional Papanicolaou smear and SurePath liquid-based cytology in the Copenhagen population screening programme for cervical cancer. Cytopathology 17:187-194.
15. Kitchener HC, Blanks R, Cubie H, Desai M, Dunn G, Legood R, et al. (2011). MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial. Health Technol Assess 15: 1-170.
16. Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T (2008). Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 123:1864-1870.
17. Lynge E, Sandegaard JL, Rebolj M (2011). The Danish National Patient Register. Scand J Public Health 39 (Suppl):30-33.
18. Moseley RP, Paget S (2002). Liquid-based cytology: is this the way forward for cervical screening? Cytopathology 13:71-82.
19. Nieminen P, Kotaniemi-Talonen L, Hakama M, Tarkkanen J, Martikainen J, Toivonen T, et al. (2007). Randomized evaluation trial on automation-assisted screening for cervical cancer: results after 777000 invitations. J Med Screen 14:23-28.
20. Pedersen CB (2011). The Danish Civil Registration System. Scand J Public Health 39 (Suppl):22-25.
21. Rebolj M, Njor SH, Lynge E (2012). Restriction of human papillomavirus DNA testing in primary cervical screening to women above age 30: systematic review. Eur J Cancer Prev 21:73-81.
22. Ronco G, Cuzick J, Pierotti P, Cariaggi MP, Dalla Palma P, Naldoni C, et al. (2007). Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ 335:28.
23. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. (2010). Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 11:249-257.
24. Siebers AG, Klinkhamer PJ, Arbyn M, Raifu AO, Massuger LF, Bulten J (2008). Cytologic detection of cervical abnormalities using liquid-based compared with conventional cytology: a randomized controlled trial. Obstet Gynecol 112:1327-1334.
25. Siebers AG, Klinkhamer PJ, Grefte JM, Massuger LF, Vedder JE, Beijers-Broos A, et al. (2009). Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA 302:1757-1764.
26. van Oortmarssen GJ, Habbema JD (1991). Epidemiological evidence for agedependent regression of pre-invasive cervical cancer. Br J Cancer 64: 559-565.